Copyright
©The Author(s) 2022.
World J Gastroenterol. Jul 7, 2022; 28(25): 2843-2853
Published online Jul 7, 2022. doi: 10.3748/wjg.v28.i25.2843
Published online Jul 7, 2022. doi: 10.3748/wjg.v28.i25.2843
Figure 1 The potential common immunological mechanisms shared between inflammatory bowel diseases and other immune-mediated inflammatory diseases.
IFN-γ: Interferon-γ; TNF-α: Tumor necrosis factor-α; IL: Interleukin; Th17 cells: IL-17 producing T helper cells; Th1 cells: T helper 1 cells; Th2 cells: T helper 2 cells; CD: Crohn’s disease; UC: Ulcerative colitis.
Figure 2 Colonoscopy showing representative endoscopic findings of a patient with primary sclerosing cholangitis and ulcerative colitis.
Right-sided predominant colitis and rectal sparing. A: Terminal ileum with normal mucosa; B: Ascending colon, diffuse inflammation with erosions, loss of vascular pattern and friability; C: Sigmoid colon, with mild erythematous inflammation and decreased vascular pattern; D: Rectum, with normal mucosa.
Figure 3 Colonoscopy showing representative endoscopic findings of a patient with Takayasu arteritis and inflammatory bowel disease.
A: Terminal ileum with normal mucosa; B and C: Sigmoid and rectosigmoid colon, respectively, with discontinuous round ulcers; D: Lower rectum, with deep and large longitudinal ulcers.
- Citation: Akiyama S, Fukuda S, Steinberg JM, Suzuki H, Tsuchiya K. Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases. World J Gastroenterol 2022; 28(25): 2843-2853
- URL: https://www.wjgnet.com/1007-9327/full/v28/i25/2843.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i25.2843